Navigation Links
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/6/2012

ted timely or receive FDA approval; risks that the launch of BYDUREON will be delayed or unsuccessful; risks that we will not be successful in our efforts to expand the reach of our sales force or in our efforts to secure an exenatide development and commercial partner outside the U.S.; risks that our expense reductions will not be as large as we expect; and other risks inherent in the drug development and commercialization process. Commercial and government reimbursement and pricing decisions and the pace of market acceptance may also affect the potential for BYETTA, SYMLIN or BYDUREON. These and additional risks and uncertainties are described more fully in the Company's recently filed Form 10-Q. Amylin disclaims any obligation to update these forward-looking statements.

(Financial information to follow)AMYLIN PHARMACEUTICALS, INC.CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data)(unaudited)Quarter ended
December 31, Twelve months ended
December 31, 2011201020112010Revenues:  Net product sales

$ 160,867$ 162,315$ 621,570$651,113  Revenues under collaborative agreements

4,06811,87529,10817,700Total revenues

164,935174,190650,678668,813Costs and expenses:  Cost of goods sold

12,31814,04248,37661,687  Selling, general and administrative

78,32362,548271,224276,880  Research and development

27,67137,510161,215183,083  Collaborative profit sharing

43,08363,071222,545257,127  Net costs to reacquire economic
interest in exenatide products

431,587-431,587-  Restructuring

1,7077,3287,19016,780Total costs and expenses

594,689184,4991,142,137795,557Operating loss

(429,754)(10,309)(491,459)(126,744)Interest and other expense, net

(31,717)(8,874)(51,940)(25,570)Net loss

$(461,471)$ (19,183)$(543,399)$(152,314)Net loss per share - basic and diluted

$ (3.15)$ (0.13)$ (3.73)$
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... UPI ), a medical device company that ... voiding dysfunctions, today reported financial results for the fiscal ... revenue for the Company,s Urgent ®  PC Neuromodulation System ... record, as compared to $3.9 million in the third ...
(Date:1/22/2015)... Calif. , Jan. 22, 2015  Amgen (NASDAQ: AMGN ... full year 2014 financial results on Tuesday, Jan. 27, 2015, after ... followed by a conference call with the investment community at 2 ... Robert A. Bradway , chairman and chief executive officer, and other ...
(Date:1/22/2015)... 2015 Increasing sophistication among enterprise buyers of language ... in 2015, says Moravia CMO, Renato ... by market research firm Common Sense Advisory, 15 percent ... translation and localization needs. "From a language industry perspective, ...
Breaking Medicine Technology:Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... SEATTLE, Oct. 31, 2011 AquaLiv Technologies (OTCBB: AQLV) ... for their NatuRx™ HIV/AIDS treatment. The company ... HIV/AIDS as an alternative medicine treatment and that approval ... "The process isn,t quite as simple as it was ...
... 2011 At the American Society of ... Institute, LLC (RRI) is presenting research results from studies involving ... advancing therapy options for dialysis patients to provide the highest ... Week 2011 takes place Nov. 8-13 in Philadelphia, PA. It ...
Cached Medicine Technology:AquaLiv Technologies Subsidiary AquaLiv, Inc. Discusses Registration In Kenya Concerning Its HIV/AIDS Treatment 2Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week 2Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week 3
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the ... , Purchasing an accidental death and dismemberment rider for ... of rider provides benefits if the insured dies in an ... form of life insurance. , AD&D is not expensive ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
(Date:1/22/2015)... 2015 EBSCO Information Services (EBSCO) ... their relationship in an effort to further promote visibility and ... EBSCO has long made AMA journals available via its subscription ... The JAMA Network. , Long known as both ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Va., May 16 CEL-SCI CORPORATION,(Amex: CVM ) ... ended,March 31, 2008., Geert Kersten, Chief Executive Officer ... our cancer therapy Multikine(R) into its,pivotal Phase III clinical ... until the completion of our dedicated manufacturing facility for,Multikine ...
... this morning, Atomic,Energy of Canada Ltd. (AECL) announced ... at Chalk River, but remains committed to providing,ongoing ... leading provider of products and services to the ... about this decision, and,the company is evaluating these ...
... be a key to decreasing the spread of cancer ... research at Washington University School of Medicine in St. ... spread, or metastasis, of breast cancer. Scientists here found ... also received a bone strengthening drug were less likely ...
... and U.S. will discuss quality in health care ... following is being,issued by the German Embassy:, ... a few months away,comprehensive health care coverage for ... Rising costs put pressure on individual citizens, employers,insurance ...
... Move More and Milk ... Their Diets, OMAHA, Neb., May ... different fad diets -- which seem to go in and out of,fashion like ... Americans -- including 25 percent of Nebraska,residents -- remain overweight or obese., ...
... Less than a week after,committing medical relief efforts ... Project HOPE, an international health education and,humanitarian assistance ... to meet the urgent medical needs for the ... which has claimed over,20,000 lives., "I am ...
Cached Medicine News:Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 2Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 3Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 4Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 5Health News:Bone drug could help prevent the spread of breast cancer 2Health News:The German Embassy Would Like to Draw Your Attention to the Press Release of the University of Minnesota Center for German & European Studies to Present Major Healthcare Forum 2Health News:Message to Nebraska Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Nebraska Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Project HOPE to Send Humanitarian Assistance to China as Humanitarian Assistance to Myanmar Continues 2
Straight shafts and serrated handle with polished finish. Teeth: Fine 1 x 2 teeth. Most popular size or model....
Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish....
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
0.12 mm, 1 x 2 teeth set at 45 degrees with 5 mm tying platform. Serrated handle with polished finish....
Medicine Products: